Carregant...
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
BACKGROUND: We have evaluated the efficacy of targeting the toxic, oligomeric form of tau protein by passive immunotherapy in a mouse model of synucleinopathy. Parkinson’s disease and Lewy body dementia are two of the most common neurodegenerative disorders and are primarily characterized by the acc...
Guardat en:
| Publicat a: | Mol Neurodegener |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5856311/ https://ncbi.nlm.nih.gov/pubmed/29544548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-018-0245-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|